Biothera is a privately held company that was founded in 1997 as Biopolymer Engineering to commercialize the development of certain natural complex carbohydrates. The company, which changed its name to Biothera in 2005, has developed and acquired significant technology for complex carbohydrate compounds based on beta 1,3/1,6 glucan that prime key immune cells. Biothera's objective is to develop and license its pharmaceutical technologies to major drug and biotech companies prior to market introduction. The company is also leveraging its technology platform to create products for the nutritional supplement, functional food, cosmetic, and animal health and nutrition markets. Biothera has more than 40 United States patents and patents pending and has additional patents in more than 20 countries.
Partial Data by Infogroup (c) 2024. All rights reserved.